Home
Log In
Shipping
Information
Contact Us
Advanced Search
DISEASES & HEALTH CONDITIONS
->
GENERAL HEALTH->
MEDICAL & SURGICAL->
MEDICAL SPECIALTIES->
MENTAL HEALTH->
NURSING->
NURSING EQUIPMENT
PHARMACEUTICAL->
Stemcells
VETERINARY->
CHARTS & MODELS
VOUCHERS
CLEARANCE TITLES
FEATURED PRODUCTS ...
Home
/
DISEASES & HEALTH CONDITIONS
/
F - L
/
Hepatitus
/
HEPATITIS C VIRUS: THE NEXT EPIDEMIC
Hepatitus
Product 10/11
Previous
Return to the Product List
Next
HEPATITIS C VIRUS: THE NEXT EPIDEMIC
larger image
ISBN 9780323402484
Author: REDDY
Publ Date: 2015-12-07
Edition:
Binding: Hardback
$165.17
Sale: $148.65
Save: 10% off
+ GST
Add to Cart:
There are over 180 million people with chronic HCV infection worldwide with between 2.7 and 3.9 million in the United States. Hepatitis C most significantly affects Asia and Africa, with rates up to 15% in countries such as Egypt and up to 30% in certain regions such as Punjab, Pakistan. Hepatitis C places a significant burden on the public health infrastructure, as it remains the leading cause of chronic liver disease, accounting for 50-75% of primary liver cancers and is responsible for 30% of all liver transplantations. It is estimated to have cost the United States $5.5 billion in 1997, comparable to the national cost of asthma, $5.8 billion in 1994.This number is only expected to grow as the current HCV population ages, increasing overall rates of compensated cirrhosis/end-stage liver disease. The evolution of directly acting anti-virals has ushered in a new era for chronic hepatitis C. Ongoing drug development strategy has involved targeting several replication steps of the virus and the hope is to see all oral therapies by late 2014 or early 2015. Thus we are at an exciting cross roads with regard to new information and challenges with HCV: rising disease burden with associated high costs, the challenges globally and in multiple patient populations, and the impending availability of effective and well tolerated treatments. Therefore there is a need to commission an exclusive issue of GCNA for HCV.
Whilst every effort is made to keep pricing information up-to-date, prices and availability are subject to change without notice. Where prices or other details have changed from those listed on the website we will contact the customer and only proceed with the order after receiving acceptance of the revised pricing.
HEPATITIS C VIRUS: THE NEXT EPIDEMIC
Home
Your IP Address is: 18.119.134.196
Copyright © 2024
Medical Books
. Powered by
Zen Cart